ADPT
Price
$25.06
Change
-$1.58 (-5.93%)
Updated
Nov 2 closing price
Capitalization
4B
One day until earnings call
Intraday BUY SELL Signals
ARRY
Price
$4.21
Change
+$0.42 (+11.05%)
Updated
Nov 3, 12:11 PM (EDT)
Capitalization
585.23M
2 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADPT vs ARRY

ADPT vs ARRY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADPT vs. ARRY commentary
Nov 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Hold and ARRY is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ADPT with price predictions
Nov 02, 2026

ADPT in downward trend: 10-day moving average moved below 50-day moving average on October 16, 2026

The 10-day moving average for ADPT crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ADPT moved out of overbought territory on September 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 23 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 63 cases where ADPT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.

ADPT moved below its 50-day moving average on November 02, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

ADPT broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on ADPT as a result. In 77 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.

The Moving Average Convergence Divergence (MACD) for ADPT just turned positive on October 27, 2026. Looking at past instances where ADPT's MACD turned positive, the stock continued to rise in 50 of 54 cases over the following month. The odds of a continued upward trend are 90%.

Following a +7.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADPT advanced for three days, in 236 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 170 of 188 cases where ADPT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (27.985) is normal, around the industry mean (65.876). P/E Ratio (-62.650) is within average values for comparable stocks, (3.542). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (13.966) is also within normal values, averaging (9.775).

The Tickeron Seasonality Score of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. ADPT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

A.I.Advisor
a Summary for ARRY with price predictions
Nov 02, 2026

ARRY's RSI Indicator ascending out of oversold territory

The RSI Oscillator for ARRY moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 38 similar instances when the indicator left oversold territory. In 32 of the 38 cases the stock moved higher. This puts the odds of a move higher at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on ARRY as a result. In 72 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for ARRY just turned positive on October 27, 2026. Looking at past instances where ARRY's MACD turned positive, the stock continued to rise in 34 of 42 cases over the following month. The odds of a continued upward trend are 81%.

Following a +13.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARRY advanced for three days, in 192 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

ARRY broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ARRY entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.896) is normal, around the industry mean (2.566). P/E Ratio (-3.958) is within average values for comparable stocks, (5.281). Projected Growth (PEG Ratio) (0.399) is also within normal values, averaging (1.699). Dividend Yield (0.000) settles around the average of (0.054) among similar stocks. P/S Ratio (0.543) is also within normal values, averaging (5.133).

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. ARRY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.

FUNDAMENTALS RATINGS
ADPT vs ARRY: Fundamental Ratings
ADPT
ARRY
OUTLOOK RATING
1..100
127
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
11
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3785
P/E GROWTH RATING
1..100
6414
SEASONALITY SCORE
1..100
2550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARRY's Valuation (11) in the Biotechnology industry is in the same range as ADPT (22) in the Hospital Or Nursing Management industry. This means that ARRY’s stock grew similarly to ADPT’s over the last 12 months.

ARRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ADPT (100) in the Hospital Or Nursing Management industry. This means that ARRY’s stock grew similarly to ADPT’s over the last 12 months.

ADPT's SMR Rating (97) in the Hospital Or Nursing Management industry is in the same range as ARRY (100) in the Biotechnology industry. This means that ADPT’s stock grew similarly to ARRY’s over the last 12 months.

ADPT's Price Growth Rating (37) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ARRY (85) in the Biotechnology industry. This means that ADPT’s stock grew somewhat faster than ARRY’s over the last 12 months.

ARRY's P/E Growth Rating (14) in the Biotechnology industry is somewhat better than the same rating for ADPT (64) in the Hospital Or Nursing Management industry. This means that ARRY’s stock grew somewhat faster than ADPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADPTARRY
RSI
ODDS (%)
Bearish Trend 7 days ago
77%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
COMPARISON
Comparison
Nov 03, 2026
Stock price -- (ADPT: $25.06 vs. ARRY: $3.80)
Brand notoriety: ADPT: Notable vs. ARRY: Not notable
ADPT represents the Medical Specialties, while ARRY is part of the Alternative Power Generation industry
Current volume relative to the 65-day Moving Average: ADPT: 116% vs. ARRY: 103%
Market capitalization -- ADPT: $4B vs. ARRY: $585.23M
ADPT [@Medical Specialties] is valued at $4B. ARRY’s [@Alternative Power Generation] market capitalization is $585.23M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Alternative Power Generation] industry ranges from $3.39K to $270.64B. The average market capitalization across the [@Medical Specialties] industry is $21.35B. The average market capitalization across the [@Alternative Power Generation] industry is $5.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 1 FA rating(s) are green while ARRY’s FA Score has 2 green FA rating(s).

  • ADPT’s FA Score: 1 green, 4 red.
  • ARRY’s FA Score: 2 green, 3 red.
According to our system of comparison, ADPT is a better buy in the long-term than ARRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 4 TA indicator(s) are bullish while ARRY’s TA Score has 4 bullish TA indicator(s).

  • ADPT’s TA Score: 4 bullish, 6 bearish.
  • ARRY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ARRY is a better buy in the short-term than ADPT.

Price Growth

ADPT (@Medical Specialties) experienced а -4.61% price change this week, while ARRY (@Alternative Power Generation) price change was +20.63% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.47%. For the same industry, the average monthly price growth was -4.50%, and the average quarterly price growth was +42.79%.

The average weekly price growth across all stocks in the @Alternative Power Generation industry was +5.34%. For the same industry, the average monthly price growth was -3.05%, and the average quarterly price growth was -41.21%.

Reported Earning Dates

ADPT is expected to report earnings on Nov 04, 2026.

ARRY is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical Specialties (-1.47% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Alternative Power Generation (+5.34% weekly)

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

View a ticker or compare two or three
ADPT
Daily Signal:
Gain/Loss:
ARRY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ADPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
-5.93%
AXON - ADPT
56%
Loosely correlated
-0.55%
NTRA - ADPT
56%
Loosely correlated
-8.54%
PSNL - ADPT
56%
Loosely correlated
-0.38%
VCYT - ADPT
55%
Loosely correlated
-2.02%
ARRY - ADPT
50%
Loosely correlated
+12.09%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEV1.840.19
+11.52%
Aptera Motors Corp
ADGM0.09N/A
+3.01%
Adagio Medical Holdings Inc.
UDR35.910.39
+1.10%
UDR
VECO37.27-1.60
-4.12%
Veeco Instruments
DDD2.66-0.12
-4.32%
3D Systems Corp